Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
about
Clinical pharmacology of midazolam in neonates and children: effect of disease-a reviewOptimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors.Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.Novel role of the serine protease inhibitor elafin in gluten-related disorders.Ontogeny of dextromethorphan O- and N-demethylation in the first year of life.Microsomal quercetin glucuronidation in rat small intestine depends on age and segment.Paediatric pharmacokinetics: key considerations.Pharmacokinetics and metabolism of oral midazolam in preterm infants.Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.Global marine pollutants inhibit P-glycoprotein: Environmental levels, inhibitory effects, and cocrystal structureIntestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile.Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and InfantsPopulation Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.Neonatal pharmacology: extensive interindividual variability despite limited size.Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies.Ontogeny of oral drug absorption processes in children.Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.A review of the toxicology and pathology of the gastrointestinal tract.Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.Theoretical pharmacokinetic drug alterations in pediatric celiac disease.Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies.Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.Human microbiota in aging and infection: A review.Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in childrenOntogeny of CYP3A and P-glycoprotein in the liver and the small intestine of the Göttingen minipig: an immunohistochemical evaluation.Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease.Buprenorphine in Neonatal Abstinence Syndrome.Age related changes in fractional elimination pathways for drugs: assessing the impact of variable ontogeny on metabolic drug-drug interactions.First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.Gene expression profiling of duodenal biopsies discriminates celiac disease mucosa from normal mucosaExtrahepatic Drug-Metabolizing Enzymes and Their SignificanceResponse to: “Prediction of Voriconazole Non-Linear Pharmacokinetics Using a Paediatric Physiologically Based Pharmacokinetic Modelling Approach”A Physiologically Based Pharmacokinetic Model for Voriconazole Disposition Predicts Intestinal First-pass Metabolism in Children
P2860
Q27006333-B654338E-52C9-431E-A370-31BF5B672952Q33628703-76A7FF3C-3843-4258-A402-50F598C18D2DQ33886854-7E425450-73F8-4435-BCBD-967795803283Q33942993-729FBD0D-BF42-4B26-A429-06CA2414BF31Q34449346-CAA1484A-17FA-4213-BB20-7AA01ECB13C4Q34575597-C9B94E8F-B787-4C54-94ED-4738CE1B7FA2Q35122803-AA064093-E601-4EF1-A15B-4CBEF4A32679Q35135940-DE6F3CC7-A78B-4A31-B012-0B4DD80C4AB2Q35803591-1F9864E6-10E5-43B0-9871-7776CFA0D433Q35912756-04F13ED4-40FF-4C5C-AC4A-FE16E979F29BQ36618687-03ABC059-99F2-4823-837B-C531AB3D2C6CQ36839792-3916DFB6-1A13-4CED-9459-77A9DEE077B8Q37106018-DB0383B7-6750-4614-9B7B-0CF8D66EB48CQ37208505-49FC1307-572F-49AB-8F88-B5D77B0DB32BQ37383670-79CB293D-A554-49F9-8FE3-245F4D832A3BQ37872786-3C822B89-0E3A-4096-80B9-5451AFB30EA6Q38000252-4EC80316-E32D-4C20-8243-4D2FF99ED776Q38003479-5A90235C-E5E3-488B-BAE1-CEAE4564BA4EQ38017723-172100A6-6037-426B-B03C-50C75D5D2951Q38086777-BBE9B64D-EFE5-4ED1-81F8-72983AD6359CQ38132657-ABCD98C3-993D-49A1-874D-9A89AFBB5278Q38534443-E94CEE02-B7ED-4BB4-8B69-0C0F31677A88Q38544086-DC8911E9-F6BC-4529-8449-8BF6E48BEAF1Q38813488-BC5196FB-0998-4AF6-AD59-2EEF0303813BQ38958282-96F7D517-85BA-41A8-9078-FBAFBC652C6FQ39038877-8C6BB299-EEA0-4739-B499-46454CCB2515Q40046097-0A6486ED-22D2-447C-BE69-5BB830FBFC10Q40772216-77B39CCE-943B-4C8E-83B0-7759C9BE1F63Q42545825-45963789-C556-4015-BE16-C9418D12579FQ45400881-105DC4AD-45B1-4F31-9380-157BFC39F62EQ46901195-B70E0350-5DE1-4CA1-B5EE-5D40404A9F0EQ47653755-0AA45031-244B-4E65-85F8-F2C34EBB05DAQ50951418-EB65EADC-D4E2-4976-878E-E6C6F668E59CQ55454780-3E9253E8-8951-44A2-AA14-DF6504304E4DQ56898869-204F6C91-C438-44B2-BEAA-E63E3DE097F1Q57258718-2F50BD51-6AA1-4308-8373-EFCA98CAEA80Q57730438-ECF32578-960F-4DE3-A6DD-35EAE564AF4FQ57730442-2BE26E0E-6A0C-4110-944F-D549EDE8DCE2
P2860
Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@ast
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@en
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@nl
type
label
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@ast
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@en
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@nl
prefLabel
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@ast
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@en
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@nl
P2093
P2860
P3181
P1476
Enterocytic CYP3A4 in a paedia ...... ac disease and cystic fibrosis
@en
P2093
C J Taylor
G T Tucker
M S Tanner
T N Johnson
P2860
P304
P3181
P356
10.1046/J.1365-2125.2001.01370.X
P407
P577
2001-05-01T00:00:00Z